Abstract
Abstract
Background
Large variations in the quality of psoriasis care lead to patients being willing to bypass the nearest physician to receive higher quality of care. However, it remains unknown whether actual travel time is associated with quality of care. This study aimed to identify perceived quality of care determinants for travel time to the physician among patients with psoriasis in Germany. Furthermore, differences in access and perceived quality of care between urban and rural areas in Germany were analyzed.
Methods
This cross-sectional observational study based on patient-level healthcare data. Perceived quality of care and treatment satisfaction were assessed from the patients’ perspective. Travel time was estimated by the patients. Multiple regression analysis with the predictors patient characteristics, system-related variables, urbanity, and patient satisfaction with treatment, was applied to identify determinants of travel time with subgroup analyses for rural and urban areas.
Results
We included 497 patients from 29 dermatological practices in Germany. There were significant differences in psoriasis care between urban and rural areas. Longer travel time was associated with lower age, higher income, higher number of consulted dermatologists since diagnosis, rural residence, more waiting time for the first appointment, lower dermatologist density, and higher patient reported treatment satisfaction.
Discussion
The results indicate an association between actual travel time and treatment satisfaction. Patients with higher perceived quality of care travel longer for their dermatological treatment. The results are also relevant to needs related planning.
Publisher
Springer Science and Business Media LLC
Reference31 articles.
1. Garcia-Doval I, Rustenbach SJ, Stern R, Dam TN, Cohen AD, Baker C, Spuls PI, Naldi L (2013) Systemic psoriasis therapy shows high between-country variation: a sign of unwarranted variation? Cross-sectional analysis of baseline data from the PSONET registries. Br J Dermatol 169:710–714. https://doi.org/10.1111/bjd.12344
2. Radtke MA, Augustin J, Blome C, Reich K, Rustenbach SJ, Schäfer I, Laass A, Augustin M (2010) How do regional factors influence psoriasis patient care in Germany? J Dtsch Dermatol Ges 8:516–524. https://doi.org/10.1111/j.1610-0387.2010.07358.x
3. Kim WB, Jerome D, Yeung J (2017) Diagnosis and management of psoriasis. Can Fam Physician 63:278–285.
4. Wennberg JE (2010) Tracking medicine: A researcher’s quest to understand health care / John E. Oxford University Press, New York, Wennberg
5. Nast A, Mrowietz U, Kragballe K, de Jong EMGJ, Puig L, Reich K, Warren RB, Werner R, Kopkow C, Schmitt J (2013) Barriers to the prescription of systemic therapies for moderate-to-severe psoriasis–a multinational cross-sectional study. Arch Dermatol Res 305:899–907. https://doi.org/10.1007/s00403-013-1372-3